Tarsons Products P/E Ratio

TARSONS • P/E ratio trend, valuation band, and sector comparison — all formatted to support journal-based trading review.
Current P/E Ratio
48.21
High Valuation
Very High - High growth expectations or significantly overvalued

Current Valuation Metrics

P/E Ratio 48.21
Current Price ₹166.46
EPS (TTM) ₹5.60
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 81.38
Historical Range 44.24 - 105.89
Percentile 33.3%

Sector Context

Sector Average 47.22
Sector Median 25.62
Sector Rank #11 of 139
Sector Percentile 7.9%

Earnings Breakdown (TTM)

TTM EPS ₹3.83
Sept 2025 ₹0.62
Mar 2025 ₹1.92

Key P/E Ratio Insights for Tarsons Products

  • Stock appears overvalued with PE of 48.21, suggesting caution for new investments
  • Current PE is 40.8% below historical average

P/E Ratio Historical Trend for Tarsons Products

Historical P/E ratio trend based on annual earnings data. Lower P/E ratios may indicate undervaluation, while higher ratios suggest growth expectations.

Historical P/E Ratio Data

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 105.89 3.83 ₹405.55 NSE High
2024 94.01 5.61 ₹527.40 NSE High
2021 44.24 18.5 ₹818.40 NSE High

Sector P/E Ratio Comparison

Comparing Tarsons Products with other companies in Healthcare sector
Sector Average
47.22
Sector Median
25.62
Lowest P/E
0.9
Highest P/E
898.7
Companies
139
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Welcure Drugs & Pharmace… WELCURE 0.9 ₹31 Low
Murae Organisor MURAE 2.86 ₹41 Low
Ind Swift Laboratories INDSWFTLAB 4.48 ₹1,128 Low
Amwill Health Care AMWILL 5.98 ₹61 Low
Medicamen Organics MEDIORG 6.37 ₹25 Low
Brooks Laboratories BROOKS 6.41 ₹127 Low
Unichem Laboratories UNICHEMLAB 7.14 ₹2,000 Low
Zenith Drugs ZENITHDRUG 7.28 ₹65 Low
Galaxy Medicare GML 7.77 ₹26 Low
Vasundhara Rasayans VRL 9.19 ₹34 Low